Altra Vue Capital, LLC Avid Bioservices, Inc. Transaction History

Altra Vue Capital, LLC

$966 Million
Q3 2024

A detailed history of Altra Vue Capital, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Altra Vue Capital, LLC holds 3,797,813 shares of CDMO stock, worth $47.3 Million. This represents 4.48% of its overall portfolio holdings.

Number of Shares

3,797,813

Previous 3,395,263 11.86%

Holding current value

$47.3 Million

Previous $24.2 Million 78.28%

% of portfolio

4.48%

Previous 2.78%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.7 - $12.45 $2.7 Million - $5.01 Million	402,550 Added 11.86%	3,797,813 $43.2 Million
Q2 2024 Aug 12, 2024	BUY	$6.34 - $9.28 $1.52 Million - $2.22 Million	239,343 Added 7.58%	3,395,263 $24.2 Million
Q1 2024 May 13, 2024	BUY	$5.86 - $8.79 $1.06 Million - $1.6 Million	181,587 Added 6.11%	3,155,920 $21.1 Million
Q4 2023 Feb 12, 2024	SELL	$4.64 - $9.56 $161,731 - $333,223	-34,856 Reduced 1.16%	2,974,333 $19.3 Million
Q3 2023 Nov 13, 2023	SELL	$9.4 - $14.04 $6.78 Million - $10.1 Million	-721,782 Reduced 19.35%	3,009,189 $28.4 Million
Q2 2023 Aug 10, 2023	BUY	$12.96 - $20.93 $195,566 - $315,833	15,090 Added 0.41%	3,730,971 $52.1 Million
Q1 2023 May 12, 2023	BUY	$13.48 - $18.79 $5.57 Million - $7.76 Million	412,921 Added 12.5%	3,715,881 $69.7 Million
Q4 2022 Feb 10, 2023	BUY	$12.61 - $18.74 $7.79 Million - $11.6 Million	618,000 Added 23.02%	3,302,960 $45.5 Million
Q3 2022 Nov 10, 2022	SELL	$15.33 - $20.36 $770,792 - $1.02 Million	-50,280 Reduced 1.84%	2,684,960 $51.3 Million
Q2 2022 Aug 12, 2022	BUY	$11.63 - $21.55 $5.6 Million - $10.4 Million	481,874 Added 21.38%	2,735,240 $41.7 Million
Q1 2022 May 12, 2022	BUY	$16.63 - $27.73 $4,490 - $7,487	270 Added 0.01%	2,253,366 $45.9 Million
Q4 2021 Jan 28, 2022	SELL	$20.7 - $34.18 $4.37 Million - $7.22 Million	-211,220 Reduced 8.57%	2,253,096 $65.7 Million
Q3 2021 Oct 29, 2021	BUY	$19.05 - $28.32 $5.28 Million - $7.85 Million	277,360 Added 12.68%	2,464,316 $53.2 Million
Q2 2021 Aug 24, 2021	BUY	$18.93 - $25.65 $20 Million - $27.1 Million	1,057,118 Added 93.56%	2,186,956 $56.1 Million
Q2 2021 Jul 30, 2021	SELL	$18.93 - $25.65 $22.9 Million - $31 Million	-1,210,362 Reduced 51.72%	1,129,838 $29 Million
Q1 2021 Aug 24, 2021	BUY	$11.86 - $21.77 $11.1 Million - $20.3 Million	934,474 Added 66.48%	2,340,200 $42.7 Million
Q1 2021 Apr 14, 2021	SELL	$11.86 - $21.77 $9.99 Million - $18.3 Million	-842,069 Reduced 37.46%	1,405,726 $25.6 Million
Q4 2020 Aug 24, 2021	BUY	$7.25 - $11.76 $5.41 Million - $8.78 Million	746,239 Added 49.7%	2,247,795 $25.9 Million
Q4 2020 Feb 09, 2021	SELL	$7.25 - $11.76 $5.92 Million - $9.6 Million	-816,474 Reduced 35.22%	1,501,556 $21.9 Million
Q3 2020 Aug 24, 2021	BUY	$6.53 - $8.6 $2.25 Million - $2.96 Million	344,681 Added 17.47%	2,318,030 $17.7 Million
Q3 2020 Oct 21, 2020	BUY	$6.53 - $8.6 $258,157 - $339,992	39,534 Added 2.04%	1,973,349 $15 Million
Q2 2020 Jul 23, 2020	SELL	$4.11 - $6.78 $67,979 - $112,141	-16,540 Reduced 0.85%	1,933,815 $12.7 Million
Q1 2020 May 01, 2020	SELL	$3.15 - $7.39 $822,424 - $1.93 Million	-261,087 Reduced 11.81%	1,950,355 $9.97 Million
Q4 2019 Jan 28, 2020	SELL	$5.01 - $8.16 $59,819 - $97,430	-11,940 Reduced 0.54%	2,211,442 $17 Million
Q3 2019 Nov 06, 2019	BUY	$5.07 - $7.08 $580,869 - $811,155	114,570 Added 5.43%	2,223,382 $11.8 Million
Q2 2019 Jul 30, 2019	BUY	$3.43 - $5.6 $457,345 - $746,687	133,337 Added 6.75%	2,108,812 $11.8 Million
Q1 2019 May 06, 2019	BUY	$3.56 - $4.82 $2.33 Million - $3.16 Million	655,507 Added 49.66%	1,975,475 $8.4 Million
Q4 2018 Feb 07, 2019	BUY	$4.04 - $6.75 $5.33 Million - $8.91 Million	1,319,968 New	1,319,968 $5.41 Million

Others Institutions Holding CDMO

# of Institutions

186

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $774M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altra Vue Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altra Vue Capital, LLC with notifications on news.

Account

Altra Vue Capital, LLC Avid Bioservices, Inc. Transaction History